Skip to main content

Federal Employee Drug Testing

T-GGD-88-40 Published: Jun 16, 1988. Publicly Released: Jun 16, 1988.
Jump To:
Skip to Highlights

Highlights

GAO discussed federal agency employee drug testing plans, and the Office of Management and Budget's (OMB) estimates of drug testing costs. GAO found that: (1) federal employees occupying testing-designated positions (TDP) would be randomly tested for drug use; (2) agencies did not uniformly classify TDP; (3) planned testing frequently varied widely; (4) applicant, post-accident, and follow-up testing significantly varied; and (5) the rate of follow-up testing of employees administratively referred for treatment ranged from once per month to three times in 2 years. GAO also found that: (1) most agencies proposed testing for marijuana, cocaine, opiates, amphetamines, and phencyclidine; (2) agency plans lacked criteria regarding disciplinary action to be taken against first-time confirmed drug users and did not establish procedures for applicants to follow to challenge a positive drug test; (3) OMB estimated a cost of $63 per person for drug testing, but did not include the cost of accident and reasonable-suspicion testing; and (4) agency plans did not provide for continuing oversight or independent monitoring of drug testing programs.

Full Report

Office of Public Affairs

Topics

Substance abuseControlled substancesDrug testingSubstance abuse treatmentFederal employeesPersonnel managementRight of privacySearch and seizureTestingDrugs